A heart patient says insurance authorization blocked scheduling his stent. His story exposes corporate gatekeeping and the urgent case for Medicare for All.
BE A PART OF REACHING ALL. YOUR PAID SUBSCRIPTION DOES IT
We are almost ready to win big, if we can reach everyone. We make our newsletters and videos free because everyone deserves the truth, regardless of their ability to pay. We are countering the billionaire and corporate media to reach as many Americans as possible. We don’t need unlimited funds, but we rely entirely on small-dollar grassroots support to keep going. Please become a paid subscriber today so we can keep flooding the zone with the truth. We can’t do this without you.
Summary
A heart patient’s call to KPFT exposes the cruelty of making medical care depend on an insurance company’s permission. Augie reported that his doctor recommended a stent, but scheduling depended on authorization from his Medicare insurer. The host later reported that Augie pressed the company and resolved the authorization issue. That outcome reinforces the central indictment: patients should receive appropriate care without fighting corporate bureaucracy.
- A doctor recommended treatment; an insurer controlled access. Augie described being required to wait for authorization before scheduling his procedure.
- Patient advocacy helped resolve the problem. The host reported that Augie pushed the insurer to decide after advice from the PDR Posse.
-
Federal investigators have documented improper barriers. An HHS inspector general review found that 13% of sampled denied Medicare Advantage authorization requests met Medicare coverage rules.
-
The burden extends far beyond one caller. KFF reports that Medicare Advantage insurers fully or partially denied 4.1 million authorization requests in 2024.
-
Medicare for All offers a structural alternative. Public financing can redirect resources toward treatment by simplifying administration and reducing the role of profit-seeking insurance intermediaries.
Augie’s experience makes the stakes unmistakable: healthcare should function as a public guarantee, with timely treatment governed by medical need.
Premium Content (Complimentary)
A Heart Patient’s Stent Delay Exposes the Cruelty of For-Profit Healthcare
A heart patient should not have to become an insurance negotiator to obtain treatment. Yet that is precisely the burden Augie described when he called KPFT. His doctor had recommended a stent. Before anyone could schedule the procedure, however, his Medicare insurer had to authorize it. The physician’s recommendation encountered a corporate checkpoint, and the patient carried the uncertainty.
The host later reported that Augie pressed the insurer and resolved the authorization issue. That matters. The segment establishes a disturbing experience: a patient reported that an insurance decision stood between a medical recommendation and scheduling care. Resolution after pressure does not make that burden acceptable.` After all, the patient could have died because of the pre-authorization’s irresponsible and inhumane delays.
This is where the promise of privatized healthcare collides with its underlying incentives. Medicare Advantage insurers receive payments to cover beneficiaries’ care. Controlling medical spending can protect their financial position, creating a conflict when patients need costly services. The HHS inspector general explicitly identified the potential incentive to deny services to increase profits in its review of inappropriate denials.
That conflict produces measurable consequences. In its 2022 report, the inspector general found that 13% of the denied prior authorization requests it reviewed met Medicare coverage rules. Those patients likely would have received approval under traditional Medicare. Investigators identified additional insurer criteria and documentation disputes among the reasons for improper barriers. Bureaucracy can obstruct care even when patients already satisfy the program’s requirements.
More recent evidence shows the enormous scale of this machinery. KFF’s analysis of 2024 data counted 52.8 million Medicare Advantage authorization determinations. Insurers fully or partially denied 4.1 million. Patients or providers appealed only 11.5% of denials, yet insurers overturned 80.7% of those appealed decisions, fully or partially. Those reversals expose a system that frequently makes people fight for care it ultimately approves.
Every appeal requires something from someone. A sick person needs stamina. A family member needs time away from work. A medical office needs staff who can chase records, navigate portals, and challenge decisions. Patients with fewer resources face greater difficulty carrying that burden. A healthcare system that rewards persistence distributes access partly according to people’s capacity to battle bureaucracy.
Conservative arguments for privatization celebrate market discipline while overlooking who bears it. The patient absorbs the uncertainty. The clinician absorbs the paperwork. The public finances the coverage. The intermediary retains power over access. Progressive healthcare policy must confront that arrangement directly and reject the idea that corporate gatekeeping represents freedom.
Medicare for All offers a different organizing principle: universal coverage through public financing, with resources directed toward care. A 2020 systematic review in PLOS Medicine examined 22 single-payer economic analyses; 19 projected first-year savings. Simplified administration represented the largest projected source of savings. These results provide substantial evidence against claims that universal public financing is inherently unaffordable.
A humane system still needs clinical standards, independent oversight, and accountability. It also needs adequate staffing and timely access. Those responsibilities belong within a framework that treats health as a right and evaluates spending by its contribution to people’s well-being.
Augie’s call gives that demand a human voice. A patient needed an answer about heart care and turned to a radio community for support. His successful intervention should inspire collective action to remove these barriers. No patient’s access to appropriate treatment should depend on having the strength, connections, or public platform to force an insurer’s attention.
Leave a Reply